Table of Content

1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America In-Vitro Diagnostics Market – by Product and Services
1.3.2 North America In-Vitro Diagnostics Market – by Technology
1.3.3 North America In-Vitro Diagnostics Market – by Application
1.3.4 North America In-Vitro Diagnostics Market – by End User
1.3.5 North America In-Vitro Diagnostics Market – by Country

2. North America In-Vitro Diagnostics Market – Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. In-Vitro Diagnostics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 NORTH AMERICA – PEST Analysis
4.3 Expert Opinion
4.4 Regulatory Scenario
4.4.1 FDA IVD Regulation
4.4.2 LDT
4.4.3 RUO

5. In-Vitro Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Chronic and Infectious Diseases
5.1.2 Rise in the Demand for In-Vitro Diagnostics During COVID-19 Pandemic
5.2 Market Restraints
5.2.1 Cumbersome Reimbursement Procedures and Stringent Regulations Regarding Product Approvals
5.3 Market Opportunities
5.3.1 Integration of IVD Technologies with Digital Health Solutions
5.4 Impact analysis

6. North America In-Vitro Diagnostics Market Analysis
6.1 North America In-Vitro Diagnostics Market Revenue Forecast and Analysis
6.1.1 Market Positioning of Key Players in In-Vitro Diagnostics Market

7. North America In-Vitro Diagnostics Market Analysis – by Products and Services
7.1 Overview
7.2 Reagents and Kits
7.2.1 Overview
7.2.2 Reagents and Kits: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.3 Instruments
7.3.1 Overview
7.3.2 Instruments: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Software and Services
7.4.1 Overview
7.4.2 Software and Services: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

8. North America In-Vitro Diagnostics Market Analysis – by Technology
8.1 Overview
8.2 Immunoassay/Immunochemistry
8.2.1 Overview
8.2.2 Immunoassay/Immunochemistry: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Clinical Chemistry
8.3.1 Overview
8.3.2 Clinical Chemistry: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Molecular Diagnostics
8.4.1 Overview
8.4.2 Molecular Diagnostics: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Microbiology
8.5.1 Overview
8.5.2 Microbiology: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Blood Glucose Self-Monitoring
8.6.1 Overview
8.6.2 Blood Glucose Self-Monitoring: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.7 Coagulation and Hemostasis
8.7.1 Overview
8.7.2 Coagulation and Hemostasis: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.8 Hematology
8.8.1 Overview
8.8.2 Hematology: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.9 Urinalysis
8.9.1 Overview
8.9.2 Urinalysis: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
8.10 Others
8.10.1 Overview
8.10.2 Others: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

9. North America In-Vitro Diagnostics Market Analysis – by Application
9.1 Overview
9.2 Infectious Disease
9.2.1 Overview
9.2.2 Infectious Disease: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Diabetes
9.3.1 Overview
9.3.2 Diabetes: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Oncology
9.4.1 Overview
9.4.2 Oncology: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Cardiology
9.5.1 Overview
9.5.2 Cardiology: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Autoimmune Disease
9.6.1 Overview
9.6.2 Autoimmune Disease: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.7 Nephrology
9.7.1 Overview
9.7.2 Nephrology: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

10. North America In-Vitro Diagnostics Market Analysis – by End User
10.1 Overview
10.2 Hospitals
10.2.1 Overview
10.2.2 Hospitals: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.3 Laboratories
10.3.1 Overview
10.3.2 Laboratories: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.4 Homecare
10.4.1 Overview
10.4.2 Homecare: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
10.5 Others
10.5.1 Overview
10.5.2 Others: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)

11. North America In-Vitro Diagnostics Market – Regional Analysis
11.1 North America In-Vitro Diagnostics Market
11.1.1 Overview
11.1.2 North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.3 North America: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.1.4 North America: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.1.5 North America: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.1.6 North America: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.1.6.1 US: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.6.1.1 Overview
11.1.6.1.2 US: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.6.1.3 US: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.1.6.1.4 US: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.1.6.1.5 US: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.1.6.1.6 US: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.1.6.2 Canada: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.6.2.1 Overview
11.1.6.2.2 Canada: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.6.2.3 Canada: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.1.6.2.4 Canada: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.1.6.2.5 Canada: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.1.6.2.6 Canada: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
11.1.6.3 Mexico: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.6.3.1 Overview
11.1.6.3.2 Mexico: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
11.1.6.3.3 Mexico: In-Vitro Diagnostics Market, by Product and Services, 2020–2030 (US$ Million)
11.1.6.3.4 Mexico: In-Vitro Diagnostics Market, by Technology, 2020–2030 (US$ Million)
11.1.6.3.5 Mexico: In-Vitro Diagnostics Market, by Application, 2020–2030 (US$ Million)
11.1.6.3.6 Mexico: In-Vitro Diagnostics Market, by End User, 2020–2030 (US$ Million)
12. Pre and Post Covid-19 Impact on North America In-Vitro Diagnostics Market
12.1 Pre and Post Covid-19 Impact
13. North America In-Vitro Diagnostics Market – Industry Landscape
13.1 Overview
13.2 Growth Strategies in North America In-Vitro Diagnostics Market
13.3 Organic Growth Strategies
13.3.1 Overview
13.4 Inorganic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 Abbott Laboratories
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 F. Hoffmann-La Roche Ltd
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Danaher Corp
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Siemens AG
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Sysmex Corp
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Thermo Fisher Scientific Inc
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Becton Dickinson and Co
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 bioMerieux SA
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Bio-Rad Laboratories Inc
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Qiagen NV
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms



List of Figures

LIST OF FIGURES

Figure 1. In-Vitro Diagnostics Tube Market Segmentation
Figure 2. In-Vitro Diagnostics Market Segmentation, by Country
Figure 3. North America In-Vitro Diagnostics Market Overview
Figure 4. Reagents and Kits Held Largest Share of Product and Services Segment in In-Vitro Diagnostics Market
Figure 5. North America In-Vitro Diagnostics Market – Leading Country Markets (US$ Million)
Figure 6. North America In-Vitro Diagnostics Market, Industry Landscape
Figure 7. North America PEST Analysis
Figure 8. North America In-Vitro Diagnostics Market Impact Analysis of Driver and Restraints
Figure 9. North America In-Vitro Diagnostics Market – Revenue Forecast and Analysis – 2020–2030
Figure 10. North America In-Vitro Diagnostics Market, by Products and Services, 2022 & 2030 (%)
Figure 11. Reagents and Kits: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Instruments: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Software and Services: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. North America In-Vitro Diagnostics Market, by Technology, 2022 & 2030 (%)
Figure 15. Immunoassay/Immunochemistry: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Clinical Chemistry: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Molecular Diagnostics: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Microbiology: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Blood Glucose Self-Monitoring: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Coagulation and Hemostasis: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Hematology: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Urinalysis: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Others: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. North America In-Vitro Diagnostics Market, by Application, 2022 & 2030 (%)
Figure 25. Infectious Disease: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 26. Diabetes: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Oncology: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Cardiology: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Autoimmune Disease: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 30. Nephrology: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 31. Others: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 32. North America In-Vitro Diagnostics Market, by Application, 2022 & 2030 (%)
Figure 33. Hospitals: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 34. Laboratories: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 35. Homecare: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 36. Others: North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 37. North America In-Vitro Diagnostics Market, by Key Country – Revenue (2022) (US$ Million)
Figure 38. North America In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 39. North America In-Vitro Diagnostics Market, by Country, 2022 & 2030 (%)
Figure 40. US: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 41. Canada: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 42. Mexico: In-Vitro Diagnostics Market – Revenue and Forecast to 2030 (US$ Million)
Figure 43. Pre and Post Covid-19 Impact on In-Vitro Diagnostics Market in North America
Figure 44. Growth Strategies in North America In-Vitro Diagnostics Market

List of Tables

LIST OF TABLES

Table 1. North America: In-Vitro Diagnostics Market, by Product and Services – Revenue and Forecast to 2030 (US$ Million)
Table 2. North America: In-Vitro Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 3. North America: In-Vitro Diagnostics Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 4. North America: In-Vitro Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 5. US: In-Vitro Diagnostics Market, by Product and Services – Revenue and Forecast to 2030 (US$ Million)
Table 6. US: In-Vitro Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 7. US: In-Vitro Diagnostics Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 8. US: In-Vitro Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 9. Canada: In-Vitro Diagnostics Market, by Product and Services – Revenue and Forecast to 2030 (US$ Million)
Table 10. Canada: In-Vitro Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 11. Canada: In-Vitro Diagnostics Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 12. Canada: In-Vitro Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 13. Mexico: In-Vitro Diagnostics Market, by Product and Services – Revenue and Forecast to 2030 (US$ Million)
Table 14. Mexico: In-Vitro Diagnostics Market, by Technology – Revenue and Forecast to 2030 (US$ Million)
Table 15. Mexico: In-Vitro Diagnostics Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 16. Mexico: In-Vitro Diagnostics Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 17. Recent Organic Growth Strategies in North America In-Vitro Diagnostics Market
Table 18. Recent Inorganic Growth Strategies in the North America In-Vitro Diagnostics Market
Table 19. Glossary of Terms, North America In-Vitro Diagnostics Market